| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA615434 | F | Inhibitory activity against Human RhinoVirus serotype-14 3C Protease | rhinovirus B14 | 12 | ALA1131817 | assay format | Scientific Literature | |
| 2. | ALA615438 | F | Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay | rhinovirus B14 | 1 | ALA1136293 | assay format | Scientific Literature | |
| 3. | ALA615439 | F | Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay | rhinovirus B14 | 1 | ALA1136293 | assay format | Scientific Literature | |
| 4. | ALA615440 | F | Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay | rhinovirus B14 | 15 | ALA1136293 | assay format | Scientific Literature | |
| 5. | ALA615441 | F | Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay; inactive | rhinovirus B14 | 1 | ALA1136293 | assay format | Scientific Literature | |
| 6. | ALA615643 | B | Inhibition of human rhinovirus 3C protease | Human rhinovirus B | 24 | ALA1129604 | single protein format | Scientific Literature | |
| 7. | ALA686949 | F | Antiviral activity tested in cytopathic effect assay using H1HeLa cells (ATCC) infected with HRV-14 | Human rhinovirus B (HRV-14) | 25 | ALA1132923 | cell-based format | Scientific Literature | |
| 8. | ALA688665 | F | Antiviral activity using H1HeLa cells (ATCC) infected with HRV-14 | Human rhinovirus B (HRV-14) | 25 | ALA1132923 | cell-based format | Scientific Literature | |
| 9. | ALA878186 | F | Chemotherapeutic index in Hela cells (chemotherapeutic index=50% cytotoxic dose/50% effective dose) | Human rhinovirus B | 30 | ALA1123419 | organism-based format | Scientific Literature | |
| 10. | ALA701643 | F | Inhibitory activity of compound towards partial or complete loss of 3C protease (HRV-14) activity in presence of 5 mM dithiothreitol (DTT); Not determined | Human rhinovirus B (HRV-14) | 23 | ALA1131036 | assay format | Scientific Literature | |
| 11. | ALA768262 | F | Effective concentration necessary to inhibit 50% HIV-induced cell death. | Human immunodeficiency virus 1 | 4 | ALA1126824 | assay format | Scientific Literature | |
| 12. | ALA877855 | F | Antiviral activity by analysis of p26 antigen concentration for HIV-2 strain EHO, replication in MT-4 cells | Human immunodeficiency virus 2 | 1 | ALA1127464 | cell-based format | Scientific Literature | |
| 13. | ALA768267 | B | Antiviral activity for inhibition of HIV-2 proteinase was assayed in infected MT-4 cells | Human immunodeficiency virus 2 | 2 | ALA1129607 | cell-based format | Scientific Literature | |
| 14. | ALA856210 | B | Compound was evaluated for inhibitory activity against HIV-2 protease | Human immunodeficiency virus 2 | 2 | ALA1127636 | single protein format | Scientific Literature | |
| 15. | ALA767016 | F | Compound was evaluated for inhibitory activity against HIV-2 protease | Human immunodeficiency virus 2 | 4 | ALA1127636 | assay format | Scientific Literature | |
| 16. | ALA767017 | B | In vitro inhibition of recombinant HIV-2 protease expressed in Escherichia coli strain X90 | Human immunodeficiency virus 2 | 9 | ALA1127657 | assay format | Scientific Literature | |
| 17. | ALA767018 | B | Tested against S2-binding site of HIV-2 protease | Human immunodeficiency virus 2 | 1 | ALA1126634 | single protein format | Scientific Literature | |
| 18. | ALA772757 | B | The inhibitory concentration was evaluated for viral strains HIV-2 ROD using a HIV protease HPLC based assay. | Human immunodeficiency virus 2 | 1 | ALA1132975 | single protein format | Scientific Literature | |
| 19. | ALA772758 | B | Binding affinity against HIV-2 protease enzyme. | Human immunodeficiency virus 2 | 1 | ALA1133572 | single protein format | Scientific Literature | |
| 20. | ALA772759 | B | Inhibitory constant against HIV-2 protease | Human immunodeficiency virus 2 | 8 | ALA1127464 | single protein format | Scientific Literature |
The page will load shortly, Thanks for your patience!